Sweden· SE-20231101000079
Vyjuvek 5 miljarder PFU/ml Suspension och gel till gel
A medicinal product containing beremagene geperpavec, registered in Sweden by Krystal Biotech Netherlands B.V..
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Beremagene Geperpavec
- Manufacturer
- Krystal Biotech Netherlands B.V.
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20231101000079
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Beremagene geperpavec in 10 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumVyjuvek 5 10*9 PFU/mlKrystal Biotech Netherlands
- CzechiaVYJUVEKKrystal Biotech Netherlands, B.V., Amsterdam
- SpainVYJUVEK 5 X 10E9 UNIDADES FORMADORAS DE PLACAS/ML EN SUSPENSION Y GEL PARA PREPARACION DE GELKrystal Biotech Netherlands B.V.
- FinlandVyjuvekKrystal Biotech Netherlands B.V.
- FranceVYJUVEK 5 x 1 000 000 000 unités formant plages /mL, de suspension et gel pour gelKRYSTAL BIOTECH NETHERLANDS (PAYS-BAS)
- IrelandVyjuvek 5 x 10⁹ PFU/ml Suspension and gel for gelKrystal Biotech Netherlands B.V.
- IcelandVyjuvekKrystal Biotech Netherlands B.V.
- Japanベレマゲン ゲペルパベククリスタルバイオテック・ジャパン
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Vyjuvek
- Liechtenstein · Vyjuvek
- Norway · Vyjuvek
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e5719eea-778e-4add-9af4-4932604b6783 GET /v1/drugs/e5719eea-778e-4add-9af4-4932604b6783?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "20231101000079",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20231101000079",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/vyjuvek-epar-product-information_sv.pdf"
}See everything about beremagene geperpavec.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.